Bill Texts: US HB2276 | 2011-2012 | 112th Congress

Bill Title: To require the Director of the United States Patent and Trademark Office to conduct a study on effective ways to provide confirming genetic diagnostic test activity where gene patents and exclusive licensing exist, and for other purposes.

Sponsorship: Partisan Bill (Democrat 1)

Status: (Introduced - Dead) 2011-08-25 - Referred to the Subcommittee on Intellectual Property, Competition and the Internet. [HB2276 Detail]

Bill Drafts

RevisionDateFormatSourceView
Introduced2011-06-24PDFLinkView

Amendments

AmendmentDateDispositionFormatSourceView
No bill amendments currently on file for US Congress HB2276

Supplemental Documents

TitleDescriptionDateFormatSourceView
No supplemental documents for US Congress HB2276 currently on file.

feedback